|
|
|
|
|
|
| Prof Dr Geerd Weyer of ICRC-Weyer, a sponsor company at the marcus evans Evolution Summit 2012, on why drug development requires flexibility in the trial design. |
London, July 6, 2012 - (ACN Newswire) - Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director, ICRC-Weyer. Every trial is unique and must be designed and treated as such, he adds.
From a contract research organisation attending the upcoming marcus evans Evolution Summit 2012, in Munich, Germany, 14 - 16 October, Prof Dr Weyer talks about clinical trials and how adaptability can accelerate clinical development.
- What would accelerate drug development and delivery/time to market?
In the last few years, many large pharmaceutical companies have been contracting out clinical development services to single, globally acting service providers. They tend to believe that the globalisation of drug development gives them strength and allows them to avoid friction in processes that they would have if they had multiple interfaces and vendors. They believe that this will help them save time and effort, but I consider this to be a one-sided view. Using the services of a niche or specialist provider could help them accelerate clinical development.
- Would this limit innovation in any way?
When it comes to innovation, a service provider that can be flexible should be preferred. Smaller organisations are able to bring in study-specific solutions, while larger organisations can bring in productivity and efficiency as they are able to streamline and standardise services.
There is a dichotomy between efficiency and productivity on the one side, and innovation on the other. However, standardisation does not always work. Processes must be adapted to each study. Clinical development is a process where innovation and flexibility are needed, at least as much as standardisation.
- What is unique about your approach and philosophy?
We are well aware of the dichotomy I mentioned before, but our philosophy has always been one of cooperation and partnership with clients and other service providers; bringing together our own strengths as a flexible specialist with the strengths of other providers.
Our philosophy is also reflected in the way we integrate services across departments. Likewise, our data systems are optimised to seamlessly integrate data from various sources, internal or external.
- What is key to clinical research and trial success?
The key is to have the right data in high quality when needed. This can be achieved by recognising the value that a specialist provider in that respective area can bring, and by not totally relying on standard solutions.
There is no single way for succeeding in clinical development. Every trial is unique and must be designed and treated as such.
About the Evolution Summit 2012
This unique forum will take place at the Hotel Four Seasons Kempinski, Munich, Germany, 14 - 16 October 2012. Offering much more than any conference, seminar or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. For more information please send an email to info@marcusevanscy.com or visit the event website at www.evolution-summit.com.
marcus evans group - life sciences / pharma sector portal: http://tiny.cc/1OCf2b
The Pharma Network - marcus evans Summits group delivers peer-to-peer information on strategic matters, professional trends and breakthrough innovations.
- LinkedIn: www.linkedin.com/groups?mostPopular=&gid=3529112
- YouTube: www.slideshare.net/MarcusEvansPharma
- Twitter: www.twitter.com/meSummitsPharma
- SlideShare: www.youtube.com/user/MarcusEvansPharma
Please note that the Summit is a closed business event and the number of participants strictly limited.
About ICRC-Weyer
Located in Berlin, Germany, ICRC-Weyer is an all-Phase CRO with almost 20 years experience. The company provides its services for the pharmaceutical and nutrition industries. These center on specialist solutions for independent medical review, expert consulting and pharmacovigilance, which are integrated with the data management, statistical analysis and medical and regulatory writing packages being offered. www.icrc-weyer.com.
Contact:
Sarin Kouyoumdjian-Gurunlian,
Press Manager, marcus evans, Summits Division
Tel: + 357 22 849 313
Email: press@marcusevanscy.com
Topic: Research / Industry Report
Source: marcus evans Summits
Sectors: Daily Finance, Daily News
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| marcus evans Summits |
| Jan 5, 2016 15:31 HKT/SGT |
|
How the Right Interior Design Can Lead to an Unforgettable Hotel Experience |
| Jan 5, 2016 14:53 HKT/SGT |
|
Why Hotels Need to Invest in Technology |
| Jan 5, 2016 14:15 HKT/SGT |
|
Why Defence Organisations Should Reconsider Their Talent Management Approach |
| Oct 23, 2015 03:00 HKT/SGT |
|
How to Distinguish the Right Emerging Markets to Invest in |
| Oct 22, 2015 21:20 HKT/SGT |
|
How to Design a Solid Privacy and Data Protection Programme |
| Oct 22, 2015 21:00 HKT/SGT |
|
The Wellness Model: A Business Strategy to Reduce Healthcare Costs |
| Oct 17, 2015 02:20 HKT/SGT |
|
The Changing Dynamics of the Oil Market |
| Oct 17, 2015 02:10 HKT/SGT |
|
How China's Slowdown Affects Global Investors |
| Oct 17, 2015 02:00 HKT/SGT |
|
How to Use Globalisation as a Marketing Tool |
| Sept 30, 2015 07:30 HKT/SGT |
|
The Need for Holistic Revenue Cycle Management Models |
| More news >> |
 |
|
|
|
